- Trials with a EudraCT protocol (93)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
93 result(s) found for: Maculopathy.
Displaying page 1 of 5.
EudraCT Number: 2006-001727-19 | Sponsor Protocol Number: 45/2006/U/Sper | Start Date*: 2006-10-03 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Triamcinolone Acetonide Intravitreal Injection for the treatment for exudative maculopathy | |||||||||||||
Medical condition: exudative maculopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001171-36 | Sponsor Protocol Number: TG-MV-001 | Start Date*: 2005-05-13 |
Sponsor Name:ThromboGenics Ltd. | ||
Full Title: A Dose-Escalation Clinical Trial of Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy for Vitreomacular Traction Maculopathy | ||
Medical condition: Vitreomacular Traction Maculopathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-004540-36 | Sponsor Protocol Number: 1076/08 | Start Date*: 2009-03-01 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Effetto della supplementazione dietetica con estratto di Crocus sativus (zafferano) sulla funzione retinica maculare nella degenerazione maculare legata all’eta’ (AMD) in fase iniziale (Protocollo ... | |||||||||||||
Medical condition: Age related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-024169-33 | Sponsor Protocol Number: SPA/UIOS-AMD-1021 | Start Date*: 2011-02-03 | |||||||||||
Sponsor Name:Sucampo Pharma Americas, Inc. | |||||||||||||
Full Title: A Single-center, Double-masked, Randomized, Pharmacodynamic Crossover Study of Ocular Blood Flow Effects of Topically-administered Unoprostone in Adults with Age-related Macular Degeneration (AMD) | |||||||||||||
Medical condition: Age related Macular Degeneration (AMD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-024001-12 | Sponsor Protocol Number: LuMi-1 | Start Date*: 2011-01-27 | |||||||||||
Sponsor Name:TYKS | |||||||||||||
Full Title: The effect of bevacizumab treatment on reading ability in age related macular degeneration | |||||||||||||
Medical condition: Age related macular degeneration of the eye, wet form | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005807-33 | Sponsor Protocol Number: Version_V3_0 | Start Date*: 2013-01-31 | |||||||||||
Sponsor Name:Medizinische Fakultät der Universität Bonn | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004675-22 | Sponsor Protocol Number: ADM-PED08 | Start Date*: 2008-10-21 | |||||||||||
Sponsor Name:University of Bonn | |||||||||||||
Full Title: Intravitreal ranibizumab in patients with retinal pigment epithelial detachments secondary to AMD | |||||||||||||
Medical condition: Pigment epithelial detachments secondary to age-relatedmacular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003766-17 | Sponsor Protocol Number: 2007-06 | Start Date*: 2007-12-06 | |||||||||||
Sponsor Name:The Eye Hospital Rotterdam | |||||||||||||
Full Title: Avastin-Injections in Age Related Macular Degeneration: Prospective Study for Optimal Frequency and Follow-up Determination | |||||||||||||
Medical condition: Age-Related Macular Degeneration (ARMD) | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006312-30 | Sponsor Protocol Number: MACPED-06-01 | Start Date*: 2007-04-05 | |||||||||||
Sponsor Name:Dept. of Ophthalmol, Semmelweis University | |||||||||||||
Full Title: A phase IV non-randomized, uncontrolled, open-label, single-center trial to evaluate the safety and efficacy of Macugen (pegaptanib sodium) given by intravitreal injections every 6 weeks in patient... | |||||||||||||
Medical condition: neovascular (wet) age-related macular degeneration (AMD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002101-39 | Sponsor Protocol Number: MD7111396 | Start Date*: 2008-09-25 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
Full Title: An extension study to protocol MD7108240; pazopanib eye drops in subjects with neovascolar age-related macular degeneration | |||||||||||||
Medical condition: Neovascular age-related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000583-25 | Sponsor Protocol Number: 311523 | Start Date*: 2008-05-23 | |||||||||||
Sponsor Name:Bayer Schering Pharma AG | |||||||||||||
Full Title: A randomized, double masked, active controlled, phase 3 study of the efficacy, safety, and tolerability of repeated doses of intravitreal VEGF Trap-Eye in subjects with neovascular age-related macu... | |||||||||||||
Medical condition: Neovascular age-related macular degeneration (AMD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) NL (Completed) AT (Completed) BE (Completed) HU (Completed) CZ (Completed) SE (Completed) ES (Completed) FR (Completed) PT (Completed) LV (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001498-13 | Sponsor Protocol Number: 24/2006/O/Sper | Start Date*: 2006-09-19 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Effetti della iniezione endovitreale di Avastin per il trattamento delle maculopatie essudative | |||||||||||||
Medical condition: exudative maculopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003763-22 | Sponsor Protocol Number: BAY73-4506/15984 | Start Date*: 2014-07-02 | ||||||||||||||||||||||||||
Sponsor Name:Bayer HealthCare AG | ||||||||||||||||||||||||||||
Full Title: A combined Phase IIa / IIb study of the efficacy, safety, and tolerability of repeated topical doses of regorafenib eye drops, in treatment-naïve subjects with neovascular age related macular degen... | ||||||||||||||||||||||||||||
Medical condition: neovascular age related macular degeneration | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: HU (Prematurely Ended) DE (Prematurely Ended) CZ (Prematurely Ended) SK (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-001301-10 | Sponsor Protocol Number: EOP1009 | Start Date*: 2004-06-14 | |||||||||||
Sponsor Name:PFIZER | |||||||||||||
Full Title: A PHASE II PROSPECTIVE, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED, DOSE-RANGING, MULTI-CENTER TRIAL TO ASSESS THE EFFECT OF PEGAPTANIB SODIUM ON FOVEAL THICKENING IN PATIENTS WITH EXUDATIVE SUBFOV... | |||||||||||||
Medical condition: AGE-RELATED MACULAR DEGENERATION | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-006014-18 | Sponsor Protocol Number: 1419 | Start Date*: 2005-12-15 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Macular structure and function after intravitreal injection of bevacizumab for wet macular degeneration a interventional study. | |||||||||||||
Medical condition: Macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003261-14 | Sponsor Protocol Number: R01 | Start Date*: 2006-08-28 | |||||||||||
Sponsor Name:Retinaklinikken Omnia | |||||||||||||
Full Title: A randomized pilot study comparing the safety and efficacy of intravireal triamcinolone acetonide given 7 days prior to or after Photodynamic therapy with Visudyne in patients with subfoveal choroi... | |||||||||||||
Medical condition: Patients with age-related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004487-53 | Sponsor Protocol Number: 2312/2007 | Start Date*: 2007-12-13 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: Pilot study of association of VEGF polymorphisms with clinical efficacy and tolerability of therapy in patients affected by exudative (neovascular) age-related macular degeneration. | |||||||||||||
Medical condition: Exudative and atrophic age-related macular degeneration. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001418-17 | Sponsor Protocol Number: trattamento con bevacizumab nella | Start Date*: 2007-11-25 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI PADOVA | |||||||||||||
Full Title: efficacy of treatment with bevacizumab,in the macular degeneration. | |||||||||||||
Medical condition: macular degeneretion aging dependent. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003204-12 | Sponsor Protocol Number: ICI21/00025 | Start Date*: 2022-03-16 | |||||||||||
Sponsor Name:Consorcio PSMAR | |||||||||||||
Full Title: Multicentre, randomised, double-blind, parallel-group, Phase III study to evaluate the genetic polymorphisms influence in the response to Ranibizumab and Bevacizumab treatment in patients with Age-... | |||||||||||||
Medical condition: age-related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007744-98 | Sponsor Protocol Number: 138/2007/O/Sper | Start Date*: 2008-03-04 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: INTERFERON alpha2 (IFN alpha2) as anti-angiogenic agent for the treatment of neovascular age-related macular degeneration: a pilot study. | |||||||||||||
Medical condition: neovascular age-related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
